Total Payments
$183,056
2024 Payments
$1,946
Companies
70
Transactions
874
Medicare Patients
12,494
Medicare Billing
$2.9M
Payment Breakdown by Category
Other$109,264 (59.7%)
Consulting$45,227 (24.7%)
Food & Beverage$18,080 (9.9%)
Travel$8,257 (4.5%)
Research$1,977 (1.1%)
Education$251.40 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $109,264 | 59 | 59.7% |
| Consulting Fee | $45,227 | 8 | 24.7% |
| Food and Beverage | $18,080 | 754 | 9.9% |
| Travel and Lodging | $8,257 | 41 | 4.5% |
| Unspecified | $1,977 | 8 | 1.1% |
| Education | $251.40 | 4 | 0.1% |
Payments by Type
General
$181,079
866 transactions
Research
$1,977
4 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $48,499 | 94 | $0 (2024) |
| Genentech USA, Inc. | $44,259 | 55 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $25,126 | 47 | $0 (2019) |
| Biogen, Inc. | $17,618 | 92 | $0 (2024) |
| SWAN VALLEY MEDICAL INCORPORATED | $14,000 | 5 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $11,465 | 106 | $0 (2024) |
| Mallinckrodt Hospital Products Inc. | $10,912 | 19 | $0 (2024) |
| Actelion Clinical Research, Inc. | $1,977 | 4 | $0 (2018) |
| EMD Serono, Inc. | $1,346 | 49 | $0 (2024) |
| ABBVIE INC. | $587.41 | 38 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,946 | 77 | EMD Serono, Inc. ($301.05) |
| 2023 | $2,346 | 95 | Biogen, Inc. ($262.67) |
| 2022 | $10,006 | 110 | Genentech USA, Inc. ($7,673) |
| 2021 | $16,357 | 123 | Mallinckrodt Hospital Products Inc. ($8,711) |
| 2020 | $18,047 | 85 | GENZYME CORPORATION ($9,258) |
| 2019 | $56,203 | 130 | GENZYME CORPORATION ($20,816) |
| 2018 | $48,287 | 159 | GENZYME CORPORATION ($18,085) |
| 2017 | $29,864 | 95 | SWAN VALLEY MEDICAL INCORPORATED ($14,000) |
All Payment Transactions
874 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: Neurology | ||||||
| 12/18/2024 | UCB, Inc. | Zilbrysq (Drug) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: Neurology | ||||||
| 12/17/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Neuroscience | ||||||
| 12/16/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Musculoskeletal | ||||||
| 12/10/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| 12/04/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | Cash or cash equivalent | $115.23 | General |
| Category: Neuroscience | ||||||
| 12/03/2024 | Genentech USA, Inc. | Ocrevus (Biological), Ocrevus Zunovo | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Immunology | ||||||
| 12/02/2024 | ANI Pharmaceuticals, Inc. | PURIFIED CORTROPHIN GEL (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Treatment of certain chronic autoimmune disorders including acute exacerbations of MS and RA | ||||||
| 11/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROLOGY | ||||||
| 11/15/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $33.28 | General |
| Category: NEUROLOGY | ||||||
| 11/12/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $27.41 | General |
| Category: Neuroscience | ||||||
| 11/11/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| 11/06/2024 | MDD US Operations, LLC | Apokyn (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: APOMORPHINE HYDROCHLORIDE | ||||||
| 11/05/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/29/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.95 | General |
| Category: Neuroscience | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $3.98 | General |
| Category: Neurology | ||||||
| 10/17/2024 | EMD Serono, Inc. | Mavenclad (Drug) | Food and Beverage | Cash or cash equivalent | $115.93 | General |
| Category: Neurology | ||||||
| 10/15/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $20.37 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Neuroscience | ||||||
| 09/25/2024 | Lilly USA, LLC | AMYVID (Drug), KISUNLA | Food and Beverage | In-kind items and services | $0.54 | General |
| Category: Neuroscience | ||||||
| 09/20/2024 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $69.75 | General |
| 09/17/2024 | ARGENX US, INC. | VYVGART (Drug), VYVGART HYTRULO | Food and Beverage | In-kind items and services | $24.59 | General |
| Category: Immunology | ||||||
| 09/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $34.82 | General |
| Category: Immunology | ||||||
| 08/28/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $30.77 | General |
| Category: Central Nervous System | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| POINT - AC058B302 | Actelion Clinical Research, Inc. | $1,977 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 3,351 | 17,971 | $1.4M | $512,796 |
| 2022 | 28 | 3,069 | 24,675 | $2.8M | $933,664 |
| 2021 | 29 | 3,201 | 23,710 | $3.0M | $997,708 |
| 2020 | 23 | 2,873 | 11,792 | $1.2M | $446,789 |
Total Patients
12,494
Total Services
78,148
Medicare Billing
$2.9M
Procedure Codes
107
All Medicare Procedures & Services
107 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 770 | 1,049 | $234,976 | $99,875 | 42.5% |
| 95819 | Measurement of brain wave activity (eeg), awake and asleep | Office | 2023 | 255 | 255 | $220,830 | $88,069 | 39.9% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 25 | 13,020 | $156,240 | $62,531 | 40.0% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Office | 2023 | 182 | 182 | $137,774 | $54,551 | 39.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 296 | 296 | $103,008 | $36,295 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 378 | 423 | $64,719 | $27,602 | 42.6% |
| 95911 | Nerve conduction, 9-10 studies | Office | 2023 | 155 | 156 | $75,816 | $25,935 | 34.2% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 104 | 104 | $64,688 | $23,555 | 36.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 141 | 251 | $47,690 | $19,731 | 41.4% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Office | 2023 | 203 | 389 | $47,847 | $19,307 | 40.4% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 21 | 259 | $56,730 | $13,307 | 23.5% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 238 | 239 | $14,340 | $6,446 | 45.0% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 56 | 56 | $14,560 | $5,871 | 40.3% |
| 92653 | Evaluation of brain response to sound for diagnosis of nervous system disorders with interpretation and report | Office | 2023 | 86 | 86 | $14,620 | $5,568 | 38.1% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 14 | 38 | $14,820 | $5,022 | 33.9% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 264 | 270 | $11,089 | $4,947 | 44.6% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 16 | 38 | $22,800 | $3,885 | 17.0% |
| 96366 | Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | Office | 2023 | 12 | 149 | $16,390 | $2,460 | 15.0% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 22 | 132 | $8,976 | $1,650 | 18.4% |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 2023 | 26 | 380 | $7,243 | $1,603 | 22.1% |
| 95930 | Measurement of nerve conduction using visual stimulation testing with report | Office | 2023 | 27 | 27 | $7,317 | $1,334 | 18.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 30 | 32 | $3,584 | $1,311 | 36.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 98 | $5,506 | $979.35 | 17.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 13 | 42 | $5,460 | $961.12 | 17.6% |
| J2350 | Injection, ocrelizumab, 1 mg | Office | 2022 | 11 | 8,400 | $1.4M | $394,085 | 28.9% |
About Dr. Stuart Shafer, MD
Dr. Stuart Shafer, MD is a Neurology healthcare provider based in Vero Beach, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1003818816.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Shafer, MD has received a total of $183,056 in payments from pharmaceutical and medical device companies, with $1,946 received in 2024. These payments were reported across 874 transactions from 70 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($109,264).
As a Medicare-enrolled provider, Shafer has provided services to 12,494 Medicare beneficiaries, totaling 78,148 services with total Medicare billing of $2.9M. Data is available for 4 years (2020–2023), covering 107 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Vero Beach, FL
- Active Since 08/11/2005
- Last Updated 02/06/2018
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1003818816
Products in Payments
- OCREVUS (Biological) $44,069
- AUBAGIO (Drug) $40,318
- ACTHAR (Biological) $36,038
- GILENYA (Drug) $10,086
- LEMTRADA (Drug) $8,077
- TYSABRI (Biological) $6,709
- TECFIDERA (Drug) $5,054
- KESIMPTA (Drug) $923.85
- Mavenclad (Drug) $413.99
- ZEPOSIA (Drug) $364.45
- APTIOM (Drug) $300.58
- AMYVID (Drug) $257.21
- NURTEC ODT (Drug) $244.73
- UBRELVY (Drug) $243.60
- RYTARY (Drug) $230.61
- MAYZENT (Drug) $221.79
- QULIPTA (Drug) $213.87
- NUEDEXTA (Drug) $199.98
- Ocrevus (Biological) $190.56
- TROKENDI XR (Drug) $183.93
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Vero Beach
Dr. Michele Ofner, Md, MD
Neurology — Payments: $9,286
Neurology $9,286
Dr. Anton Lotman, M.d, M.D
Neurology — Payments: $6,001
Neurology $6,001
Dr. Richa Singh, Md, MD
Neurology — Payments: $1,945
Neurology $1,945
Dr. Dalwyn Sealy, M.d, M.D
Neurology — Payments: $266.90
Neurology $266.90
Dr. Kendra Cagniart, M.d, M.D
Neurology — Payments: $220.60
Neurology $220.60
Gemma Mendoza, M.d, M.D
Neurology
Neurology